...
首页> 外文期刊>Asia-Pacific Biotech News >COMMERCIALIZING REGENERATIVE MEDICINE TECHNOLOGIES: ACHIEVING SCALE IN CHINA?
【24h】

COMMERCIALIZING REGENERATIVE MEDICINE TECHNOLOGIES: ACHIEVING SCALE IN CHINA?

机译:再生医学技术的商业化:在中国实现规模化?

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Regenerative medicine is an emerging field of biomedicine. Based on new exciting breakthroughs in the field of cell biology and developmental biology, it has great potential to treat a range of human diseases. Whilst the term, regenerative medicine, is widely used, it is now considered to embrace cell therapies, biomaterials applications, tissue engineering and regeneration-stimulating compounds among its key technology platforms. Regenerative therapies help the body to heal itself. Cells, "genetic constructs", and other biological building blocks, together with bio-engineered materials, are used to help the body repair its own damaged tissue or to create simple replacement "spare parts", for example bone, cartilage and lung tissue. Some bioactive materials can also improve repair of damaged tissue without the addition of cells.
机译:再生医学是生物医学的新兴领域。基于细胞生物学和发育生物学领域新的令人兴奋的突破,它具有治疗多种人类疾病的巨大潜力。虽然术语“再生医学”得到了广泛使用,但现在已被认为在其关键技术平台中将细胞疗法,生物材料应用,组织工程学和刺激再生的化合物包括在内。再生疗法可帮助身体自愈。细胞,“基因构建体”和其他生物构件以及生物工程材料可用于帮助人体修复自身受损的组织或创建简单的替代“备件”,例如骨骼,软骨和肺组织。一些生物活性物质还可以在不添加细胞的情况下改善受损组织的修复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号